National Institute of Neurological Disorders and Stroke; Notice of Meetings, 28829 [E8-11089]
Download as PDF
Federal Register / Vol. 73, No. 97 / Monday, May 19, 2008 / Notices
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Name of Committee: Microbiology,
Infectious Diseases and AIDS Initial Review
Group, Microbiology and Infectious Diseases
Research.
Committee Date: June 12, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Allerton Hotel, 701 N. Michigan
Avenue, The Venetian Room, 23rd Floor,
Chicago, IL 60611.
Contact Person: Annie Walker-Abbey, PhD,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
NIH/NIAID/DHHS, 6700B Rockledge Drive,
Rm. 3126, Bethesda, MD 20892–7616, 301–
451–2671, aabbey@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of meetings of the
National Advisory Neurological
Disorders and Stroke Council.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Dated: May 9, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–10949 Filed 5–16–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Amended Notice of Meeting
pwalker on PROD1PC71 with NOTICES
Notice is hereby given of a change in
the meeting of the National Advisory
Mental Health Council, May 22, 2008,
10:30 a.m. to May 23, 2008, 12:30 p.m.,
National Institutes of Health, Building
31, 31 Center Drive, Bethesda, MD
20892 which was published in the
Federal Register on April 23, 2008,
73FR21967.
The Closed Grant Review session of
the National Advisory Mental Health
Council will start at 11 a.m. instead of
10:30 a.m. This Closed session on May
22, 2008, will be at the Neuroscience
Center, 6001 Executive Boulevard,
Rockville, MD. The meeting is partially
Closed to the public.
Dated: May 9, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–11087 Filed 5–16–08; 8:45 am]
BILLING CODE 4140–01–M
VerDate Aug<31>2005
17:18 May 16, 2008
Jkt 214001
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of
Meetings
Name of Committee: National Advisory
Neurological Disorders and Stroke, Council
Clinical Trials Subcommittee.
Date: May 29, 2008.
Closed: 8 a.m. to 9 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, C Wing,
Conference Room 10, Bethesda, MD 20892.
Open: 9 a.m. to 10 a.m.
Agenda: To discuss clinical trials policy.
Place: National Institutes of Health,
Building 31, 31 Center Drive, C Wing,
Conference Room 10, Bethesda, MD 20892.
Contact Person: Deborah G Hirtz, MD,
Acting Director, Clinical Trials Cluster,
National Institute of Neurological Disorders
and Stroke, National Institute of Health, 6001
Executive Blvd., Suite 2212, Bethesda, MD
20892, (301) 496–5821, hirtz@ninds.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council
Basic and Preclinical Programs
Subcommittee.
Date: May 29, 2008.
Closed: 8 a.m. to 8:30 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, C Wing,
Conference Room 7, Bethesda, MD 20892.
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
28829
Open: 8:30 a.m. to 10 a.m.
Agenda: To discuss basic and preclinical
programs policy.
Place: National Institutes of Health,
Building 31, 31 Center Drive, C Wing,
Conference Room 7, Bethesda, MD 20892.
Contact Person: Jill E. Heemskerk, PhD,
Acting Chief, Technology Development,
National Institute of Neurological Disorders
and Stroke, National Institutes of Health,
6001 Executive Boulevard, Suite 2229, MSC
9527, Bethesda, MD 20892–9527, (301) 496–
1779, jh440o@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Information is also available on the
Institute’s/Center’s home page: https://
www.ninds.nih.gov, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: May 12, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–11089 Filed 5–16–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel; ZAA1 CC–12 Member
Conflict.
Date: June 26–27, 2008.
Time: 8 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Legacy Hotel, 1775 Rockville Pike,
Rockville, MD 20852.
E:\FR\FM\19MYN1.SGM
19MYN1
Agencies
[Federal Register Volume 73, Number 97 (Monday, May 19, 2008)]
[Notices]
[Page 28829]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-11089]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of meetings of
the National Advisory Neurological Disorders and Stroke Council.
The meetings will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Neurological Disorders and
Stroke, Council Clinical Trials Subcommittee.
Date: May 29, 2008.
Closed: 8 a.m. to 9 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, 31 Center
Drive, C Wing, Conference Room 10, Bethesda, MD 20892.
Open: 9 a.m. to 10 a.m.
Agenda: To discuss clinical trials policy.
Place: National Institutes of Health, Building 31, 31 Center
Drive, C Wing, Conference Room 10, Bethesda, MD 20892.
Contact Person: Deborah G Hirtz, MD, Acting Director, Clinical
Trials Cluster, National Institute of Neurological Disorders and
Stroke, National Institute of Health, 6001 Executive Blvd., Suite
2212, Bethesda, MD 20892, (301) 496-5821, hirtz@ninds.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Advisory Neurological Disorders and
Stroke Council Basic and Preclinical Programs Subcommittee.
Date: May 29, 2008.
Closed: 8 a.m. to 8:30 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, 31 Center
Drive, C Wing, Conference Room 7, Bethesda, MD 20892.
Open: 8:30 a.m. to 10 a.m.
Agenda: To discuss basic and preclinical programs policy.
Place: National Institutes of Health, Building 31, 31 Center
Drive, C Wing, Conference Room 7, Bethesda, MD 20892.
Contact Person: Jill E. Heemskerk, PhD, Acting Chief, Technology
Development, National Institute of Neurological Disorders and
Stroke, National Institutes of Health, 6001 Executive Boulevard,
Suite 2229, MSC 9527, Bethesda, MD 20892-9527, (301) 496-1779,
jh440o@nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Information is also available on the Institute's/Center's home
page: https://www.ninds.nih.gov, where an agenda and any additional
information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS)
Dated: May 12, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-11089 Filed 5-16-08; 8:45 am]
BILLING CODE 4140-01-M